Company profile
AlveoliX AG
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
Source: startup.ch
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
Source: startup.ch
By continuing to use this website you agree with our TERMS AND CONDITIONS